InsidersTradesSigma
Track the Aileron Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 9 December 2024 (Acquisition). Among the most active insiders: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO. The full history is free.
Analysts rate Aileron Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Aileron Therapeutics, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias basadas en péptidos para el cáncer y otras enfermedades graves. La empresa cotiza en NASDAQ bajo el símbolo ALRN.